Nice post legume
This brings about a topic that is of interest to me and that is valuing some of these biotechs particularly when you should be receiving around 5 to 8 percent return per year and if they are 5 years away from making a profit if they are lucky they have a long way to go before they are a productive investment.
I would be interested in hearing your constructive thoughts and reasons on how much of a chance you think osl have on achieving ce mark. Sorry made the assumption you were a doctor.
Useless Valuation Van Leeuwenhoeck Institute initiates Research Coverage, page-67
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $9.475K | 1.927M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 23999517 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5643803 | 6 |
View Market Depth
| Last trade - 15.42pm 26/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |